Channing Capital Management LLC Sells 316,619 Shares of Integer Holdings Co. (NYSE:ITGR)

Channing Capital Management LLC lessened its holdings in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 41.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 450,862 shares of the medical equipment provider's stock after selling 316,619 shares during the period. Channing Capital Management LLC owned 1.35% of Integer worth $44,671,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Fuller & Thaler Asset Management Inc. increased its stake in shares of Integer by 497.0% in the 3rd quarter. Fuller & Thaler Asset Management Inc. now owns 536,343 shares of the medical equipment provider's stock valued at $42,065,000 after acquiring an additional 446,508 shares in the last quarter. Victory Capital Management Inc. increased its stake in Integer by 8.9% in the third quarter. Victory Capital Management Inc. now owns 1,632,549 shares of the medical equipment provider's stock valued at $128,041,000 after purchasing an additional 133,898 shares in the last quarter. FMR LLC raised its holdings in shares of Integer by 12.8% during the third quarter. FMR LLC now owns 863,938 shares of the medical equipment provider's stock valued at $67,759,000 after purchasing an additional 97,851 shares during the period. Envestnet Asset Management Inc. boosted its position in shares of Integer by 50.7% during the 3rd quarter. Envestnet Asset Management Inc. now owns 254,904 shares of the medical equipment provider's stock worth $19,992,000 after purchasing an additional 85,711 shares in the last quarter. Finally, Congress Asset Management Co. MA grew its stake in shares of Integer by 24.8% in the 3rd quarter. Congress Asset Management Co. MA now owns 374,748 shares of the medical equipment provider's stock valued at $29,391,000 after buying an additional 74,510 shares during the period. Institutional investors own 99.29% of the company's stock.

Insiders Place Their Bets

In related news, VP Tommy P. Thomas sold 1,500 shares of the stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total transaction of $171,000.00. Following the sale, the vice president now directly owns 2,813 shares of the company's stock, valued at $320,682. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.00% of the company's stock.

Integer Trading Up 1.2 %

Shares of ITGR stock traded up $1.35 on Friday, hitting $111.27. 224,856 shares of the company's stock traded hands, compared to its average volume of 511,895. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.01 and a current ratio of 3.32. The stock has a market capitalization of $3.73 billion, a price-to-earnings ratio of 38.50, a P/E/G ratio of 1.65 and a beta of 1.12. The company's fifty day simple moving average is $114.24 and its 200 day simple moving average is $101.33. Integer Holdings Co. has a one year low of $69.40 and a one year high of $123.99.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.12 by $0.02. The business had revenue of $414.80 million for the quarter, compared to analyst estimates of $412.78 million. Integer had a net margin of 6.01% and a return on equity of 11.25%. The company's revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.87 EPS. Equities analysts forecast that Integer Holdings Co. will post 5.27 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ITGR. Bank of America raised Integer from a "neutral" rating to a "buy" rating and raised their price objective for the company from $105.00 to $135.00 in a research note on Monday, April 15th. CL King started coverage on shares of Integer in a research note on Thursday, March 14th. They set a "buy" rating and a $137.00 price target for the company. Benchmark restated a "buy" rating and set a $130.00 price objective on shares of Integer in a report on Friday, April 26th. Finally, KeyCorp lifted their price objective on shares of Integer from $123.00 to $139.00 and gave the company an "overweight" rating in a report on Tuesday, April 9th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $120.50.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.